Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

158.00 +3.19 (+2.06%)
Streaming Delayed Price Updated: 5:03 AM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Moderna to Present at Credit Suisse 28th Annual Healthcare Conference
Moderna to present at Credit Suisse 28th Annual Healthcare Conference. 
From Business Wire News Releases
Moderna Named Top Employer by Science for Fifth Consecutive Year
Moderna named top employer by Science for fifth consecutive year. 
From Business Wire News Releases
Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)
Moderna receives FDA Fast Track designation for Propionic Acidemia program (mRNA-3927). 
From Business Wire News Releases
Moderna to Report Third Quarter 2019 Financial Results on Wednesday, November 6th, 2019
Moderna to report third quarter 2019 financial results at 8:00 a.m. ET on Wednesday, November 6th, 2019. 
From Business Wire News Releases
Flagship Pioneering Unveils Cygnal Therapeutics
Company is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More 
From PR Newswire
Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019
Moderna to present data from two of its prophylactic mRNA vaccines at IDWeek 2019. 
From Business Wire News Releases
Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer
Torque Therapeutics, a clinical stage, product-platform company developing proprietary, first-in-class Deep Primed™ adoptive cell transfer therapeutics with uniquely broad potential to treat patients... 
From Business Wire News Releases
Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927)
Moderna announces open IND for Propionic Acidemia program (mRNA-3927). 
From Business Wire News Releases
Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University
Moderna announces mRNA immunotherapy research collaboration with Harvard University. 
From Business Wire News Releases
Moderna to Present at Upcoming Investor Conferences
Moderna to present at upcoming investor conferences. 
From Business Wire News Releases
Flagship Pioneering Unveils Omega Therapeutics and Appoints Seasoned BioPharma Executive Mahesh Karande as President and Chief Executive Officer
Flagship Pioneering Unveils Omega Therapeutics and Appoints Seasoned BioPharma Executive Mahesh Karande as President and Chief Executive Officer 
From Business Wire News Releases
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
Moderna, Inc. announces positive Phase 1 results for the first systemic messenger RNA therapeutic encoding a secreted protein (mRNA-1944). 
From Business Wire News Releases
Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials
Moderna, Inc. announces positive interim results from its Phase 1 CMV vaccine (mRNA-1647) study and progress toward Phase 2 and pivotal trials. 
From Business Wire News Releases
Moderna Appoints Tracey Franklin as Chief Human Resources Officer
Moderna, Inc. today announced that Tracey Franklin has been appointed Chief Human Resources Officer. 
From Business Wire News Releases
Moderna to Host R&D Day on September 12, 2019
Moderna to host R&D Day on Thursday, September 12 in New York City. 
From Business Wire News Releases
Moderna to Present at Upcoming Investor Conferences
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results
Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results 
From Business Wire News Releases
Moderna to Report Second Quarter 2019 Financial Results on Wednesday, August 7th, 2019
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna to Present at ROTH RNA Revolution Conference
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna to Present at BMO 2019 Prescriptions for Success Healthcare Conference
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna to Present at Goldman Sachs 40th Annual Global Healthcare Conference
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting
Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Growth at Flagship Pioneering Leads to New Executive Appointments
Expertise Added to Support Growth of Transformative Companies Originated by Flagship Labs 
From PR Newswire
Moderna Announces Publication of Preclinical Data for Chikungunya Antibody Program
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Life Science Cares Announces Inaugural Group of Founding Corporate Members
Twenty-seven life science companies have signed on as Founding Members of Life Science Cares, a non-profit collective effort of the Life Science industry to eliminate the impact of poverty in the... 
From Business Wire News Releases
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates
MODERNA REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES 
From Business Wire News Releases
Moderna to Present at Bank of America Merrill Lynch 2019 Health Care Conference
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
Moderna to Present Preclinical Data at 2019 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... 
From Business Wire News Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.